Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

360 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Monoclonal antibodies in chronic lymphocytic leukemia.
Ferrajoli A, Faderl S, Keating MJ. Ferrajoli A, et al. Expert Rev Anticancer Ther. 2006 Sep;6(9):1231-8. doi: 10.1586/14737140.6.9.1231. Expert Rev Anticancer Ther. 2006. PMID: 17020457 Review.
A phase II study of the combination of rituximab and granulocyte macrophage colony stimulating factor as treatment of patients with chronic lymphocytic leukemia.
Strati P, Tong WG, Vitale C, Wierda WG, O'Brien S, Brown JR, Weng WK, Kipps T, Keating MJ, Ferrajoli A. Strati P, et al. Among authors: ferrajoli a. Leuk Lymphoma. 2015 Jun;56(6):1878-80. doi: 10.3109/10428194.2014.974049. Epub 2014 Nov 20. Leuk Lymphoma. 2015. PMID: 25311497 Free PMC article. Clinical Trial. No abstract available.
SnapShot: chronic lymphocytic leukemia.
Ciccone M, Ferrajoli A, Keating MJ, Calin GA. Ciccone M, et al. Among authors: ferrajoli a. Cancer Cell. 2014 Nov 10;26(5):770-770.e1. doi: 10.1016/j.ccell.2014.10.020. Epub 2014 Nov 10. Cancer Cell. 2014. PMID: 25517752 Free article.
Ofatumumab and Lenalidomide for Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia: Correlation between Responses and Immune Characteristics.
Vitale C, Falchi L, Ten Hacken E, Gao H, Shaim H, Van Roosbroeck K, Calin G, O'Brien S, Faderl S, Wang X, Wierda WG, Rezvani K, Reuben JM, Burger JA, Keating MJ, Ferrajoli A. Vitale C, et al. Among authors: ferrajoli a. Clin Cancer Res. 2016 May 15;22(10):2359-67. doi: 10.1158/1078-0432.CCR-15-2476. Epub 2016 Jan 5. Clin Cancer Res. 2016. PMID: 26733610 Free PMC article. Clinical Trial.
Richter Syndrome in Chronic Lymphocytic Leukemia.
Vitale C, Ferrajoli A. Vitale C, et al. Among authors: ferrajoli a. Curr Hematol Malig Rep. 2016 Feb;11(1):43-51. doi: 10.1007/s11899-016-0300-y. Curr Hematol Malig Rep. 2016. PMID: 26830086 Free article.
Autoimmune cytopenias in patients with chronic lymphocytic leukemia treated with ibrutinib.
Vitale C, Ahn IE, Sivina M, Ferrajoli A, Wierda WG, Estrov Z, Konoplev SN, Jain N, O'Brien S, Farooqui M, Keating MJ, Wiestner A, Burger JA. Vitale C, et al. Among authors: ferrajoli a. Haematologica. 2016 Jun;101(6):e254-8. doi: 10.3324/haematol.2015.138289. Epub 2016 Mar 24. Haematologica. 2016. PMID: 27013651 Free PMC article. Clinical Trial. No abstract available.
360 results